Pharma Stocks
-
Is This Pharma Giant a Silent Stock Cheat Code?
Everyone’s busy chasing shiny AI stocks while Novartis AG quietly moves billions in the background. Is this pharma OG a…
Read More » -
Sleeper Stock or Total Flop? Here’s the Real Talk You Need
Sinopharm is moving while everyone’s doomscrolling tech. Is this low-key pharma giant a must-cop value play or a walking red…
Read More » -
Hard Look At Fidson, May&Baker, Neimeth And Mecure In 2026
Pharma Stocks: Hard Look at Fidson, May&Baker, Neimeth and Mecure in 2026 In Nigeria, healthcare, especially pharmaceuticals, remains one of…
Read More » -
Zealand Pharma A/S’ (CPH:ZEAL) Share Price Is Matching Sentiment Around Its Revenues
With a price-to-sales (or “P/S”) ratio of 3.5x Zealand Pharma A/S (CPH:ZEAL) may be sending very bullish signals at the…
Read More » -
Cipla’s Stock Tests Investor Patience As Pharma Rally Leaves It Behind
While India’s pharma index has pushed toward new highs, Cipla’s stock has drifted sideways, caught between solid fundamentals and stubborn…
Read More » -
Cipla’s Stock Tests Investor Patience As Pharma Rally Leaves It Behind
While India’s pharma index has pushed toward new highs, Cipla’s stock has drifted sideways, caught between solid fundamentals and stubborn…
Read More » -
Innocan Pharma (INNPD) plans NYSE American listing, offering
HERZLIA, Israel and CALGARY, AB, Jan. 2, 2026 /PRNewswire/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the…
Read More » -
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
HERZLIA, Israel and CALGARY, AB, Jan. 2, 2026 /PRNewswire/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the…
Read More » -
Senores Pharmaceuticals Ltd Hits All-Time High, Marking a Significant Milestone
Record-Breaking Price Movement On 2 Jan 2026, Senores Pharmaceuticals Ltd’s stock price touched an intraday high of ₹849, just 0.52%…
Read More » -
Pfizer’s Dividend Trap or Deep Value? Analyzing the Pharma Giant as Shares Languish Below $30
As the calendar turns to January 1, 2026, Pfizer Inc. (NYSE: PFE) finds itself in a position that would have…
Read More »